Ledger.Open graph →
SEC Form D · filed April 7, 2021

Icosavax, Inc

Offering
$99.7M
Sold
$99.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Seattle, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Peter A. Kolchinsky · Seattle, WADirectorMark A. Mcdade · Seattle, WADirectorEric A. Moessinger · Seattle, WADirectorJason A. Hafler · Seattle, WADirectorCharles A. Richardson · Seattle, WAExecTerry A. Gould · Seattle, WADirectorAdam K. Simpson · San Diego, CAExec · DirectorNiranjan A. Kanesa-Thasan · Seattle, WAExecDouglas A. Holtzman · Seattle, WAExecCassia A. Cearley · Seattle, WAExecTadataka Yamada, M.D · Seattle, WADirectorPeter A. Kolchinsky · Seattle, WADirectorCharles A. Richardson · Seattle, WAExecMark A. Mcdade · Seattle, WADirectorTerry A. Gould · Seattle, WADirectorAdam K. Simpson · Seattle, WAExec · DirectorEric A. Moessinger · Seattle, WADirectorNiranjan A. Kanesa-Thasan · Seattle, WAExecDouglas A. Holtzman · Seattle, WAExecJason A. Hafler · Seattle, WADirectorCassia A. Cearley · Seattle, WAExecTadataka Yamada, M.D · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗